摘要
将６８例寒性哮喘患者随机分为两组，中药组３４例用温阳通络合剂，对照组３４例用舒喘灵片和二丙酸倍氯米松气雾剂。结果：中药组近期总有效率与对照组比较无显著性差异（Ｐ＞０．０５）；停药１年后追访，中药组临床治愈９例（２６．４７％），对照组临床治愈２例（５．８８％），中药组临床治愈率明显优于对照组（Ｐ＜０．０５）。中药组在消除虚寒症状、改善肺通气功能、调节外周血液淋巴细胞β肾上腺素能受体、降低血清中５－羟色胺浓度方面明显优于对照组（Ｐ＜０．０５～０．０１）。为中药温阳通络合剂用于防治寒性哮喘提供了客观依据。
Sixty-eight asthma patients of Cold type were randomly divided into two groups, 34 for each group. The treated group was treated with Chinese herbal medicine Wenyang Tongluo Mixture (WYTLM), the control group was treated with Salbutamol orally and beclomethasone dipropionate aerosol. After 8 weeks of treatment, the results showed that there was no significant difference between the short-term total effective rate of the two groups (P >0.05). Results of followup 1 year after withdrawal of treatment, showed that 9 patients (26.47%) in the treated group and 2 (5.88%) in the. control group were cured clinically, it indicated that the long-term curative rate of the former group was higher than that of the latter group significantly (P<0.05). And the effect of treated group on eliminating Asthenia-Cold symptoms, improving pulmonary ventilation function, regulating adrenergicβ-receptors of peripheral blood lymphocyte and decreasing the serum level of 5-hydroxytryptamine was more superior to that of control group (P<0.05～0.01). This study provided some objective basis for using WYTLM in preventing and treating asthma of Cold type.
出处
《中国中西医结合杂志》
CAS
CSCD
北大核心
1996年第9期529-532,共4页
Chinese Journal of Integrated Traditional and Western Medicine
关键词
温阳通络合剂
寒性
哮喘
中医药疗法
Wenyang Tongluo Mixture, asthma of Cold type, adrenergic β-receptor, 5-hydroxytryptamine
